(S)-3-Amino-4-((carboxymethyl)amino)-4-oxobutanoic acid, 95%, 250mg

E-Plan phase EPLPH S40x/0.65 objective. Working distance 0.64 mm

4-Methoxyphenyl 4-((6-(acryloyloxy)hexyl)oxy)benzoate, 97.0%, 100g

2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid, 98.0%, 10g

1-(2-Chloro-5-(trifluoromethyl)pyridin-3-yl)ethan-1-one, 95+%, 500mg

4-Bromo-5-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 98.0%, 10g

N-Cyclohexylacetoacetamide, 250mg

Allyl(chloromethyl)dimethylsilane, 95%, 1g

3-(4-chlorophenyl)cyclobutan-1-one, 95.0%, 1g

5-Bromo-3-methyl-1H-indole, 95.0%, 5g

1-(3-BROMOPHENYL)-3-METHYL-1H-PYRAZOLE, 95%, 1g

Methyl 1-bromocyclobutanecarboxylate, 98.0%, 1g

1'-Boc-1,2-dihydro-2-oxo-spiro[4H-3,1-benzoxazine-4,4'-piperidine], 95.0%, 1g